Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

Diabetes/Metabolism Research and Reviews

Volumn 16, Issue 6, 2000, Pages 442-447

  Törn, Carina ^a   Landin Olsson, Mona ^a   Östman, Jan ^b   Scherstén, Bengt ^c   Arnqvist, Hans ^d   Blohmé, Göran ^e   Björk, Elisabeth ^f   Bolinder, Jan ^b   Eriksson, Jan ^g   Littorin, Bengt ^h   Nyström, Lennarth ⁱ   Sundkvist, Göran ^a   Lernmark, Åke ^j  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h LUND UNIVERSITY   (Sweden)

ⁱ UMEÅ UNIVERSITY   (Sweden)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Body mass index (BMI); C peptide; Diabetes classification; GADA; IA 2A; ICA

Indexed keywords

AUTOANTIBODY; C PEPTIDE; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; ISOENZYMES; PREDICTIVE VALUE OF TESTS; SWEDEN;

EID: 0034508418     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-7560(2000)9999:9999<::AID-DMRR152>3.0.CO;2-T     Document Type: Article

References (22)

1. A comparison of childhood and adult Type 1 diabetes mellitus
2. Factors influencing the magnitude, duration, and rate of fall of B-cell function in Type 1 (insulin-dependent) diabetes children followed for two years from their clinical diagnosis
3. Difficulties in classifying diabetes at presentation in the young adult
4. Diagnostic heterogeneity of diabetes in lean young adults: Classification based on immunological and genetic parameters
5. Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls
6. Islet cell and thyrogastric antibodies in 633 consecutive 15-34 years old patients in the Diabetes Incidence Study in Sweden (DISS)
7. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
8. Islet cell antibodies identify late Type I diabetes in patients aged 35-75 years at diagnosis
9. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
10. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus
11. UKPDS 25: Autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in Type 2 diabetes
12. Islet cell antibodies and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment
13. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients
14. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulindependent) diabetes mellitus
15. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type 1 diabetes
16. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
17. 3H recombinant human ligands
18. ICA512 autoantibody radioassay
19. Clinical and genetic characteristics of Type 2 diabetes with and without GAD antibodies
20. Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population based cohort of lean newly diagnosed patients aged 30-54 years
21. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM